A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease.
6-hydroxydopamine
Parkinson’s disease
agonist
alpha-synuclein
microglia
neurodegeneration
regulatory T cells
vasoactive intestinal peptide
Journal
Frontiers in cellular neuroscience
ISSN: 1662-5102
Titre abrégé: Front Cell Neurosci
Pays: Switzerland
ID NLM: 101477935
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
07
2019
accepted:
02
09
2019
entrez:
18
10
2019
pubmed:
18
10
2019
medline:
18
10
2019
Statut:
epublish
Résumé
A paradigm shift has emerged in Parkinson's disease (PD) highlighting the prominent role of CD4
Identifiants
pubmed: 31619964
doi: 10.3389/fncel.2019.00421
pmc: PMC6759633
doi:
Types de publication
Journal Article
Langues
eng
Pagination
421Subventions
Organisme : NINDS NIH HHS
ID : R01 NS036126
Pays : United States
Organisme : NINDS NIH HHS
ID : P01 NS043985
Pays : United States
Organisme : NIDA NIH HHS
ID : P01 DA028555
Pays : United States
Organisme : NIMH NIH HHS
ID : P30 MH062261
Pays : United States
Organisme : NINDS NIH HHS
ID : P01 NS031492
Pays : United States
Organisme : NIMH NIH HHS
ID : P01 MH064570
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG043540
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS034239
Pays : United States
Informations de copyright
Copyright © 2019 Mosley, Lu, Olson, Machhi, Yan, Namminga, Smith, Shandler and Gendelman.
Références
Allergy Asthma Clin Immunol. 2011 Nov 29;7:19
pubmed: 22126441
Brain Behav Immun. 2010 Jan;24(1):138-52
pubmed: 19765643
J Immunol. 2001 Feb 15;166(4):2522-30
pubmed: 11160313
Gen Comp Endocrinol. 2007 Jun-Jul;152(2-3):165-75
pubmed: 17572414
Acta Physiol (Oxf). 2016 Jan;216(1):42-89
pubmed: 25728499
Curr Opin Investig Drugs. 2005 Nov;6(11):1116-23
pubmed: 16312132
Br J Pharmacol. 2013 Jun;169(3):512-23
pubmed: 23517078
ASN Neuro. 2011 Oct 06;3(4):null
pubmed: 21895607
NPJ Parkinsons Dis. 2015;1:null
pubmed: 27148593
Front Cell Neurosci. 2018 Apr 27;12:114
pubmed: 29755324
Arthritis Res Ther. 2005;7(5):R1034-45
pubmed: 16207319
Pharmacol Rev. 2004 Jun;56(2):249-90
pubmed: 15169929
Lancet Neurol. 2017 Oct;16(10):769-771
pubmed: 28807669
Am J Dig Dis. 1978 Apr;23(4):373-6
pubmed: 208414
NPJ Parkinsons Dis. 2017 Mar 23;3:10
pubmed: 28649610
J Immunol. 2010 Mar 1;184(5):2261-71
pubmed: 20118279
Brain Behav Immun. 2015 Feb;44:167-175
pubmed: 25305591
J Neuropathol Exp Neurol. 2008 Dec;67(12):1149-58
pubmed: 19018246
Parkinsonism Relat Disord. 2005 Dec;11(8):493-8
pubmed: 16154792
Front Immunol. 2019 Mar 29;10:628
pubmed: 30984192
Immun Inflamm Dis. 2014 Dec;2(4):226-38
pubmed: 25866630
J Immunol. 2013 Jun 1;190(11):5516-25
pubmed: 23630352
J Gastroenterol Hepatol. 2000 Apr;15(4):457-60
pubmed: 10824894
J Neuroimmune Pharmacol. 2008 Jun;3(2):59-74
pubmed: 18202920
Endocr Connect. 2015 Mar;4(1):18-26
pubmed: 25504760
J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50
pubmed: 26520433
Adv Immunol. 2010;108:111-65
pubmed: 21056730
Neurol Res. 2017 Jan;39(1):65-72
pubmed: 27786097
Glia. 2014 Aug;62(8):1313-27
pubmed: 24801739
Scand J Immunol. 2008 Dec;68(6):572-8
pubmed: 19055696
J Neurosci Res. 2003 Jun 1;72(5):595-602
pubmed: 12749024
J Appl Physiol (1985). 2014 Aug 15;117(4):383-91
pubmed: 24947028
Mol Cell Biol. 2010 May;30(10):2537-51
pubmed: 20231362
Mol Neurodegener. 2018 May 21;13(1):26
pubmed: 29783988
Nat Neurosci. 2017 Jun;20(6):854-863
pubmed: 28436982
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a009381
pubmed: 22315722
Curr Pharm Des. 2018;24(39):4693-4701
pubmed: 30636594
Nat Med. 2001 May;7(5):563-8
pubmed: 11329057
Science. 2014 Aug 8;345(6197):660-5
pubmed: 25104383
Immunopharmacol Immunotoxicol. 2015;37(4):393-9
pubmed: 26211726
Am J Respir Crit Care Med. 2010 Aug 15;182(4):540-8
pubmed: 20442436
Cold Spring Harb Symp Quant Biol. 2014;79:1-9
pubmed: 25948638
Brain. 2011 May;134(Pt 5):1293-314
pubmed: 21596768
J Leukoc Biol. 2005 Dec;78(6):1327-38
pubmed: 16204628
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1053-8
pubmed: 11792830
Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G16-G25
pubmed: 28385693
Neurol Genet. 2016 Jul 26;2(4):e90
pubmed: 27504496
J Neurosci. 2000 May 15;20(10):3622-30
pubmed: 10804204
Acta Physiol (Oxf). 2015 Feb;213(2):442-52
pubmed: 25422088
Immunol Cell Biol. 2010 Oct;88(7):734-45
pubmed: 20309012
J Mol Neurosci. 2016 Jun;59(2):280-9
pubmed: 27115671
Hum Vaccin Immunother. 2014;10(4):852-67
pubmed: 24670306
J Clin Invest. 2009 Jan;119(1):182-92
pubmed: 19104149
Cephalalgia. 2017 Aug;37(9):823-827
pubmed: 27250233
J Neuroimmune Pharmacol. 2012 Dec;7(4):927-38
pubmed: 23054369
Sci Adv. 2016 Sep 09;2(9):e1600960
pubmed: 27626074
J Neurosci Methods. 2011 Aug 30;200(1):29-35
pubmed: 21723319
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
Cell Immunol. 2011;267(2):124-32
pubmed: 21295288
Nat Neurosci. 2013 Nov;16(11):1662-70
pubmed: 24097044
Neurobiol Dis. 2012 Mar;45(3):939-53
pubmed: 22182688
J Mol Neurosci. 2010 Jun;41(2):278-87
pubmed: 19953344
PLoS One. 2008 Jan 02;3(1):e1376
pubmed: 18167537
Peptides. 2005 May;26(5):827-36
pubmed: 15808913
Amino Acids. 2013 Jul;45(1):25-39
pubmed: 22139413
Neurobiol Dis. 2017 Nov;107:32-40
pubmed: 27546055
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13854-9
pubmed: 11698667
Acta Neurol Scand. 2012 Apr;125(4):260-4
pubmed: 21651502
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13562-7
pubmed: 16150720
EMBO Mol Med. 2013 Jan;5(1):64-79
pubmed: 23143995
Exp Parasitol. 2015 Dec;159:72-8
pubmed: 26358268
J Immunol Res. 2018 Apr 16;2018:4784268
pubmed: 29850629
J Pharmacol Exp Ther. 2005 Aug;314(2):745-52
pubmed: 15872042
Int J Dev Neurosci. 2019 Oct;77:26-38
pubmed: 31026497
Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S218-21
pubmed: 22166440
J Neurosci. 2015 Dec 16;35(50):16463-78
pubmed: 26674871
Sci Rep. 2017 Jul 26;7(1):6594
pubmed: 28747670
J Immunol. 2004 Jun 15;172(12):7289-96
pubmed: 15187104
J Neurosci. 2015 Feb 4;35(5):1905-20
pubmed: 25653351
Pharmacol Rep. 2005 May-Jun;57(3):307-20
pubmed: 15985713
FASEB J. 2004 Sep;18(12):1325-34
pubmed: 15333575
Cell Immunol. 2010;265(2):105-10
pubmed: 20716449
J Immunol Res. 2018 Aug 1;2018:6043710
pubmed: 30155495
J Mol Neurosci. 2012 Jan;46(1):51-7
pubmed: 21850490
J Neuroimmunol. 2013 Dec 15;265(1-2):1-10
pubmed: 24210793
J Immunol. 2009 Apr 1;182(7):4137-49
pubmed: 19299711
J Neuroinflammation. 2018 Jul 12;15(1):205
pubmed: 30001736
J Neurosci Res. 2018 Jun;96(6):951-968
pubmed: 28488363
PLoS One. 2014 Aug 07;9(8):e104183
pubmed: 25101851
Transl Neurodegener. 2014 Nov 13;3(1):25
pubmed: 25671101
N Engl J Med. 1975 Jul 24;293(4):155-60
pubmed: 166313
EMBO Mol Med. 2016 Oct 4;8(10):1162-1183
pubmed: 27596437
Peptides. 2007 Sep;28(9):1620-1
pubmed: 17719695
Mol Med Rep. 2015 Oct;12(4):6105-11
pubmed: 26239429
N Engl J Med. 1983 Dec 15;309(24):1482-5
pubmed: 6316136
Gastroenterology. 1992 Aug;103(2):377-82
pubmed: 1634056
J Neurochem. 2007 Mar;100(6):1449-57
pubmed: 17241127
Glia. 2008 Aug 1;56(10):1091-103
pubmed: 18442091
Cell. 2014 Mar 13;156(6):1139-1152
pubmed: 24630718
Neurotherapeutics. 2016 Jul;13(3):635-46
pubmed: 27329163
Cephalalgia. 2015 Apr;35(4):310-6
pubmed: 24847167
Peptides. 2011 Jan;32(1):131-7
pubmed: 20923692
Lancet. 1973 Jul 7;2(7819):14-6
pubmed: 4123289
Immunol Cell Biol. 2012 Feb;90(2):178-86
pubmed: 21445087
J Mol Neurosci. 2012 Nov;48(3):565-73
pubmed: 22544516
J Clin Invest. 2012 Apr;122(4):1164-71
pubmed: 22466658
Brain Behav Immun. 2008 Jan;22(1):35-41
pubmed: 17826030
Arch Pharm Res. 2017 Oct;40(10):1117-1128
pubmed: 28952032
Nature. 2013 Nov 28;503(7477):521-4
pubmed: 24097352
Curr Pharm Des. 2010;16(9):1063-80
pubmed: 20030612
Brain Res. 2011 Apr 6;1383:43-53
pubmed: 21281617
Peptides. 2010 Nov;31(11):2035-45
pubmed: 20691743
Mediators Inflamm. 2014;2014:813045
pubmed: 24991091
Curr Pharm Des. 2011;17(10):961
pubmed: 21524249
Ann N Y Acad Sci. 2006 Jul;1070:276-81
pubmed: 16888178
FASEB J. 2003 May;17(8):944-6
pubmed: 12626429